Fresh Recalls

FDAClass II · Drug · Recall D-0789-2026 · Recalled September 2, 2026

Clobetasol Propionate Cream USP recall — Lupin Pharmaceuticals Inc.

Agency report date: September 2, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Clobetasol Propionate Cream USP
Company / brand
Lupin Pharmaceuticals
Lot / serial / date codes
Lot#: KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026
Distribution
USA Nationwide
Agency product description and boundaries

Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed content uniformity specifications.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Clobetasol Propionate Cream USP recall status

3. Open the official notice or contact

Official recall ID
D-0789-2026
Brand
All Lupin Pharmaceuticals recalls
Classification
Class II
Units affected
5082 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Naples, FL, United States
Firm address
5801 Pelican Bay Blvd Ste 500, N/A, 34108-2734

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026
Distribution
USA Nationwide
Firm notified the public via
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
FDA event ID
99544
Recall initiated
August 3, 2026
FDA classified
August 26, 2026
FDA report date
September 2, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page